Search results for “Esfenvalerate” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 107 patents, we discovered top 22 key players by total patent application. Sumitomo Chemical Co., Ltd., BASF AB, Bayer CropScience NV are dominant in this area. They take 64.49% of the total patent filing.
Tokyo-to, Japan
Patent: 30
Sweden
Patent: 22
Belgium
Patent: 17
FMC Corp.
Pennsylvania, United States
Patent: 6
EIDP, Inc.
Delaware, United States
Patent: 5
Bayern, Germany
Patent: 4
Bayer Intellectual Property GmbH
Nordrhein-Westfalen, Germany
Patent: 4
Anhui Sheng, China
Patent: 2
Nordrhein-Westfalen, Germany
Patent: 1
Tokyo-to, Japan
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 10 patents applied in the last 5 years. We discover 4 most active companies in this area. The fast-growing Sumitomo Chemical Co., Ltd., BASF AB, FMC Corp. take 70.00% of patent filing during this period.
Tokyo-to, Japan
Patent: 3
Sweden
Patent: 2
FMC Corp.
Pennsylvania, United States
Patent: 2
Guangxi Zhuangzu Zizhiqu, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 10 patents in last 5 years, we discover 1 new entrants.
Guangxi Zhuangzu Zizhiqu, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 universities and scientific research institutions by total patent application.
Shandong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: